10-of-my-most-popular-text-to-image-series-prompts-78b0897e
generate a bunch of images, then you curate the results to handpick the best ones
ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) prediction for drug candidates. Use for assessing drug-likeness, PK properties, and safety risks early in drug discovery. Keywords: ADMET, PK, toxicity, drug-likeness, DILI, hERG, bioavailability
Suivez les instructions du dépôt pour votre agent. Consultez les fichiers et dépendances avant l’installation.
SkillHub CLI
skillhub install huifer/admet-predictionExaminez la source et la compatibilité, puis suivez les étapes d’installation.
Donnez le lien à votre agent et demandez-lui d’examiner instructions et dépendances avant d’expliquer les étapes.
Predict ADMET properties to prioritize compounds for development.
/admet "CC1=CC=C(C=C1)CNC" --full
/pk-prediction --library compounds.sdf --threshold 0.7
/toxicity-screen CHEMBL210 --include hERG,DILI,Ames
| Property | Prediction | Model |
|---|---|---|
| Absorption | Caco-2, HIA, Pgp | ML/QSAR |
| Distribution | VDss, PPB, BBB | ML/QSAR |
| Metabolism | CYP inhibition, clearance | ML/QSAR |
| Excretion | Clearance, half-life | ML/QSAR |
| Toxicity | hERG, DILI, Ames, mutagenicity | ML/QSAR |
# ADMET Profile: CHEMBL210 (Osimertinib)
## Summary
| Property | Value | Status |
|----------|-------|--------|
| Drug-likeness | Pass | ✓ |
| Lipinski Ro5 | 0 violations | ✓ |
| VEBER | Pass | ✓ |
| PAINS | 0 alerts | ✓ |
| Brenk | 0 alerts | ✓ |
## Absorption
| Property | Prediction | Confidence |
|----------|------------|-------------|
| HIA | 98% | High |
| Caco-2 | 15.2 × 10⁻⁶ cm/s | High |
| Pgp substrate | Yes | Medium |
| F30% | 65% | Medium |
## Distribution
| Property | Prediction | Confidence |
|----------|------------|-------------|
| VDss | 5.2 L/kg | Medium |
| PPB | 95% | High |
| BBB | Yes | High |
| CNS MPO | 5.5 | Good |
## Metabolism
| Property | Prediction | Confidence |
|----------|------------|-------------|
| CYP3A4 substrate | Yes | High |
| CYP3A4 inhibitor | Yes | Medium |
| CYP2D6 inhibitor | No | High |
| CYP2C9 inhibitor | No | Medium |
| Clearance | 8.5 mL/min/kg | Low |
## Excretion
| Property | Prediction | Confidence |
|----------|------------|-------------|
| Renal clearance | 10% | Medium |
| Half-life | 48 hours | High |
## Toxicity
| Property | Prediction | Confidence |
|----------|------------|-------------|
| hERG inhibition | No | High |
| DILI | Concern | Medium |
| Ames mutagenicity | Negative | High |
| Carcinogenicity | Negative | Medium |
| Respiratory toxicity | No | Low |
## Recommendations
**Strengt...
Ces informations proviennent de l’analyse indexée et peuvent être anciennes. Vérifiez les fichiers actuels.
# ADMET Prediction Skill Predict ADMET properties to prioritize compounds for development. ## Quick Start ``` /admet "CC1=CC=C(C=C1)CNC" --full /pk-prediction --library compounds.sdf --threshold 0.7 /toxicity-screen CHEMBL210 --include hERG,DILI,Ames ``` ## What's Included | Property | Prediction | Model | |----------|------------|-------| | Absorption | Caco-2, HIA, Pgp | ML/QSAR | | Distribution | VDss, PPB, BBB | ML/QSAR | | Metabolism | CYP inhibition, clearance | ML/QSAR | | Excretion | Clearance, half-life | ML/QSAR | | Toxicity | hERG, DILI, Ames, mutagenicity | ML/QSAR | ## Output Structure ```markdown # ADMET Profile: CHEMBL210 (Osimertinib) ## Summary | Property | Value | Status | |----------|-------|--------| | Drug-likeness | Pass | ✓ | | Lipinski Ro5 | 0 violations | ✓ | | VEBER | Pass | ✓ | | PAINS | 0 alerts | ✓ | | Brenk | 0 alerts | ✓ | ## Absorption | Property | Prediction | Confidence | |----------|------------|-------------| | HIA | 98% | High | | Caco-2 | 15.2 × 10⁻⁶ cm/s | High | | Pgp substrate | Yes | Medium | | F30% | 65% | Medium | ## Distribution | Property | Prediction | Confidence | |----------|------------|-------------| | VDss | 5.2 L/kg | Medium | | PPB | 95% | High | | BBB | Yes | High | | CNS MPO | 5.5 | Good | ## Metabolism | Property | Prediction | Confidence | |----------|------------|-------------| | CYP3A4 substrate | Yes | High | | CYP3A4 inhibitor | Yes | Medium | | CYP2D6 inhibitor | No | High | | CYP2C9 inhibitor | No | Medium | | Clearance | 8.5 mL/min/kg | Low | ## Excretion | Property | Prediction | Confidence | |----------|------------|-------------| | Renal clearance | 10% | Medium | | Half-life | 48 hours | High | ## Toxicity | Property | Prediction | Confidence | |----------|------------|-------------| | hERG inhibition | No | High | | DILI | Concern | Medium | | Ames mutagenicity | Negative | High | | Carcinogenicity | Negative | Medium | | Respiratory toxicity | No | Low | ## Recommendations **Strengt...
generate a bunch of images, then you curate the results to handpick the best ones
generate a bunch of images, then you curate the results to handpick the best ones
Productivity system based on Maya calendar with 13 natural tones for project management and personal development
Set up and use 1Password CLI (op). Use when installing the CLI, enabling desktop app integration, signing in (single or multi-account), or reading/injecting/running secrets via op.